Author: Nishisaka N. Jones R.F. Maini A. Morse P. Wang C.Y. Haas G.P.
Publisher: Elsevier
ISSN: 1078-1439
Source: Urologic Oncology: Seminars and Original Investigations, Vol.3, Iss.5, 1997-09, pp. : 148-153
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Prognostic Factors of Immunotherapy in Metastatic Renal Cell Carcinoma
Medical Oncology, Vol. 20, Iss. 4, 2003-12 ,pp. :
By Kobayashi Hirohito Tanaka Yoshimasa Yagi Junji Osaka Yukinari Nakazawa Hayakazu Uchiyama Takehiko Minato Nagahiro Toma Hiroshi
Cancer Immunology, Immunotherapy, Vol. 56, Iss. 4, 2007-04 ,pp. :
By Riechelmann Herbert Wiesneth Markus Schauwecker Peter Reinhardt Peter Gronau Silke Schmitt Anita Schroen Carsten Atz Judith Schmitt Michael
Cancer Immunology, Immunotherapy, Vol. 56, Iss. 9, 2007-09 ,pp. :
Anti-Angiogenic Therapy in Renal Cell Carcinoma
Recent Patents on Anti-Cancer Drug Discovery, Vol. 5, Iss. 1, 2010-01 ,pp. :